SE8304818L - Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan - Google Patents

Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan

Info

Publication number: SE8304818L
Authority: SE; Sweden
Prior art keywords: spasmolytic; local; anticular; anestic; medicine
Prior art date: 1983-09-08

Application number

SE8304818A

Other languages

English (en)

Other versions

SE462420B (sv

SE8304818D0 (sv

Inventor

L Benes

A Babulova

V Nosalova

S Stolc

A Borovansky

V Bauer

Original Assignee

Slovenska Akademia Vied

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-09-13

Filing date

1983-09-08

Publication date

1985-03-09

1983-09-08 Application filed by Slovenska Akademia Vied filed Critical Slovenska Akademia Vied

1983-09-08 Publication of SE8304818D0 publication Critical patent/SE8304818D0/sv

1985-03-09 Publication of SE8304818L publication Critical patent/SE8304818L/sv

1990-06-25 Publication of SE462420B publication Critical patent/SE462420B/sv

Links

230000003444 anaesthetic effect Effects 0.000 title abstract 2
239000000812 cholinergic antagonist Substances 0.000 title abstract 2
230000002048 spasmolytic effect Effects 0.000 title abstract 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
229940069428 antacid Drugs 0.000 abstract 2
239000003159 antacid agent Substances 0.000 abstract 2
230000001458 anti-acid effect Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
HVYGHQWGUABUST-NHCUHLMSSA-N [(1r,2r)-2-pyrrolidin-1-ylcyclohexyl] n-(3-pentoxyphenyl)carbamate Chemical compound CCCCCOC1=CC=CC(NC(=O)O[C@H]2[C@@H](CCCC2)N2CCCC2)=C1 HVYGHQWGUABUST-NHCUHLMSSA-N 0.000 abstract 1
230000000767 anti-ulcer Effects 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
150000007522 mineralic acids Chemical class 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SE8304818A 1983-09-13 1983-09-08 Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan SE462420B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19833333008 DE3333008A1 (de)	1983-09-13	1983-09-13	Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung

Publications (3)

Publication Number	Publication Date
SE8304818D0 SE8304818D0 (sv)	1983-09-08
SE8304818L true SE8304818L (sv)	1985-03-09
SE462420B SE462420B (sv)	1990-06-25

Family

ID=6208945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8304818A SE462420B (sv)	1983-09-13	1983-09-08	Anvaendning av trans-2-(1-pyrrolidinyl)-cyklohexylestern av 3-n-pentyloxikarbanilsyra foer framstaellning av ett laekemedel med magsaarslaekande verkan

Country Status (6)

Country	Link
JP (1)	JPS6067421A (sv)
BE (1)	BE897823A (sv)
CH (1)	CH654743A5 (sv)
DE (1)	DE3333008A1 (sv)
NL (1)	NL8303098A (sv)
SE (1)	SE462420B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6103380A (en)	1998-06-03	2000-08-15	Cabot Corporation	Particle having an attached halide group and methods of making the same

1983
- 1983-08-31 CH CH4782/83A patent/CH654743A5/de not_active IP Right Cessation
- 1983-09-07 NL NL8303098A patent/NL8303098A/nl not_active Application Discontinuation
- 1983-09-08 SE SE8304818A patent/SE462420B/sv not_active IP Right Cessation
- 1983-09-13 DE DE19833333008 patent/DE3333008A1/de active Granted
- 1983-09-19 JP JP58171407A patent/JPS6067421A/ja active Granted
- 1983-09-26 BE BE0/211577A patent/BE897823A/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
NL8303098A (nl)	1985-04-01
JPS6067421A (ja)	1985-04-17
SE462420B (sv)	1990-06-25
CH654743A5 (en)	1986-03-14
BE897823A (fr)	1984-01-16
JPH045003B2 (sv)	1992-01-30
DE3333008C2 (sv)	1990-06-21
DE3333008A1 (de)	1985-03-21
SE8304818D0 (sv)	1983-09-08

Similar Documents

Publication	Publication Date	Title
KR930702022A (ko)	1993-09-08	인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
MX9700081A (es)	1997-04-30	Composiciones farmaceuticas de tacrina.
ES2170069T3 (es)	2002-08-01	1-alfa-hidroxiprevitamina d para administracion oral.
ES2188782T3 (es)	2003-07-01	Formulaciones farmaceuticas que contienen darifenacina.
RU98111594A (ru)	2000-05-20	Фармацевтические композиции, включающие флурбипрофен
WO2005065069A3 (en)	2005-09-22	Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
IS1889B (is)	2003-09-19	Innöndunarefnasambönd
CA2326517A1 (en)	1999-10-07	New galenic preparations of meloxicam for oral administration
EP0724885A4 (en)	1997-06-25	COMPOSITION ADMINISTERED BY NASAL AND PREPARATION CONTAINING THE SAME
KR910009273A (ko)	1991-06-28	위장관계 통증 치료용 약제학적 조성물
KR970061244A (ko)	1997-09-12	치매 치료용 약학 조성물
ATE99172T1 (de)	1994-01-15	Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
RU95101385A (ru)	1996-12-27	Продукты, содержащие g-csf и tnf связующие протеина
ATE257704T1 (de)	2004-01-15	Pharmazeutische zusammensetzungen enthaltend norastemizol.
ES2119748T3 (es)	1998-10-16	Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
ES2175663T3 (es)	2002-11-16	Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
ES8307496A1 (es)	1983-08-16	Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
EG19302A (en)	1994-11-30	Compound with gastric acid inhibitory effect and process for its preparation
OA07029A (fr)	1983-12-31	Le chlorure de gallium, nouveau médicament anti-cancéreux.
IT1241079B (it)	1993-12-29	Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
KR890004705A (ko)	1989-05-09	항바이러스성 제제
SE8304818D0 (sv)	1983-09-08	A medicine having anti-ulcer, spasmolytic and locally anesthetic effect
DE3688787D1 (de)	1993-09-02	Herstellung eines arzneimittels gegen arthritis und rheumatismus.
AR002946A1 (es)	1998-05-27	Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
RU2678821C1 (ru)	2019-02-04	Фармацевтическая композиция для лечения заболеваний полости рта с противовоспалительным и антибактериальным действиями

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 8304818-1

Format of ref document f/p: F

1996-06-24

NUG

Patent has lapsed

Ref document number: 8304818-1

Format of ref document f/p: F